ivabradine has been researched along with losartan potassium in 4 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 24,390 | 2,493 | 5,408 |
| Protein | Taxonomy | ivabradine (IC50) | losartan potassium (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.53 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, D; Clark, AL; Cleland, JG; Coletta, AP; Torabi, A | 1 |
| Haensch, CA; Isenmann, S | 1 |
| Adhyaru, B; Raj, L | 1 |
| Aggarwal, D; Aronow, WS; Kantharia, B; Narasimhan, B; Satish, P | 1 |
3 review(s) available for ivabradine and losartan potassium
| Article | Year |
|---|---|
[Postural orthostatic tachycardia syndrome: current concepts in pathophysiology, diagnosis and therapeutic options].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Benzazepines; Blood Pressure; Cardiotonic Agents; Cholinesterase Inhibitors; Electrocardiography; Erythropoietin; Fludrocortisone; Heart Rate; Humans; Ivabradine; Joint Instability; Midodrine; Postural Orthostatic Tachycardia Syndrome; Pyridostigmine Bromide; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Terminology as Topic | 2011 |
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents | 2016 |
Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies.
Topics: COVID-19; Deamino Arginine Vasopressin; Erythropoietin; Fludrocortisone; Humans; Immunoglobulins, Intravenous; Iron; Ivabradine; Midodrine; Postural Orthostatic Tachycardia Syndrome; Therapies, Investigational; Thioctic Acid; Vitamin D | 2022 |
1 other study(ies) available for ivabradine and losartan potassium
| Article | Year |
|---|---|
Clinical trials update from the European Society of Cardiology Meeting 2010: SHIFT, PEARL-HF, STAR-heart, and HEBE-III.
Topics: Adrenergic beta-Antagonists; Benzazepines; Clinical Trials as Topic; Comorbidity; Cyclic Nucleotide-Gated Cation Channels; Drug Therapy, Combination; Erythropoietin; Heart Failure; Hematinics; Humans; Hyperkalemia; Ivabradine; Myocardial Infarction; Polymers; Renal Insufficiency; Stem Cell Transplantation | 2010 |